Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modulation of Cilia Motility by Vortex-Ultrasound-Induced Shear Stress.

ACS nano·2026

Same author

Ultrasound-responsive oxygen-loaded microbubbles induce vascular normalization and immune modulation in pancreatic ductal adenocarcinoma.

International journal of pharmaceutics·2026

Same author

Quantitative ultrasound scatteromics for characterization of reconstructed neopharyngeal tissue: Assessment of postoperative speech outcome after total laryngopharyngectomy.

Ultrasonics·2026

Same author

External validation of MIRACLE2, rCAST, and TTM scores for neurological outcomes in comatose out-of-hospital cardiac arrest survivors: A multi-center study.

Heart & lung : the journal of critical care·2026

Same author

Beyond total release: Fragment-resolved metrics for ultrasound microbubble-mediated drug delivery.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Enhancing prestin oligomerization for superior sonogenetics.

Theranostics·2026

Search research articles

Related Experiment Video

Updated: Feb 28, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Current progress in antivascular tumor therapy.

Yi-Ju Ho¹, Tzu-Chia Wang¹, Ching-Hsiang Fan¹

¹Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan.

Drug Discovery Today

|June 20, 2017

Summary

Antivascular therapy targets tumor blood vessels to inhibit cancer growth. This approach enhances conventional treatments by altering the tumor microenvironment, offering new avenues for cancer research.

More Related Videos

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Related Experiment Videos

Last Updated: Feb 28, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Area of Science:

Oncology
Vascular Biology
Cancer Therapy

Background:

Tumor vasculature is essential for supplying oxygen, nutrients, and drugs.
Antivascular therapy directly targets tumor vessels to impede tumor growth.
This strategy can overcome limitations of traditional cancer treatments.

Purpose of the Study:

To review current progress in antivascular therapy.
To provide an overview of antivascular therapeutic strategies.
To inform future development and application of antivascular therapy in cancer research.

Main Methods:

Review of existing literature on antivascular therapies.
Analysis of mechanisms of action for vascular disrupting agents and ultrasound-stimulated microbubble destruction.
Examination of how antivascular therapy modifies the tumor microenvironment.

Main Results:

Antivascular therapy reduces tumor blood perfusion by damaging vascular endothelial cells.
Chemical toxicity (vascular disrupting agents) and physical effects (ultrasound-stimulated microbubble destruction) are key mechanisms.
Antivascular therapy can break down vessel wall barriers, improving drug delivery and efficacy.

Conclusions:

Antivascular therapy represents a promising strategy in cancer treatment.
This approach can be combined with conventional chemotherapy or radiotherapy for enhanced outcomes.
Further research and development are needed to optimize antivascular therapy applications.